Single-use Bronchoscopes Market Sees Uptick as Healthcare Prioritizes Infection Prevention

The global single-use bronchoscopes market has experienced rapid growth, expanding at a CAGR of 19.2% between 2019 and 2024 to reach a valuation of US$473.6 million in 2024. Looking ahead, the market is projected to accelerate further, with sales forecasted to grow at a CAGR of 23.6%, reaching an estimated US$2.39 billion by 2032. This impressive growth underscores the increasing adoption of single-use bronchoscopes as a safer, more convenient alternative to reusable devices, especially in the context of infection control and rising respiratory health concerns worldwide.

According to recent analysis by Persistence Market Research, the chronic obstructive pulmonary disease (COPD) indication accounted for 29.5% of the market share in 2024, highlighting the significant role bronchoscopes play in managing chronic respiratory conditions. Additionally, single-use bronchoscopes contributed to 28.2% of the global single-use endoscopes market sales in the same year, reflecting their growing importance in minimally invasive diagnostics and therapeutics.

Bronchoscopy remains a vital diagnostic tool in pulmonary medicine, enabling clinicians to investigate causes of radiographic abnormalities such as infections, tumors, and bleeding (hemoptysis). Beyond diagnostics, single-use bronchoscopes are instrumental in therapeutic procedures, including airway secretion clearance, resolving mucus plugs, relieving airway obstructions, and assisting in airway management. The convenience of disposability eliminates cross-contamination risks, reduces the need for costly sterilization processes, and ensures device availability, further driving market demand.